Cargando…

The dual role of necrostatin-1 in Parkinson’s disease models

Detalles Bibliográficos
Autores principales:	Alegre-Cortés, Eva, Martínez-Chacón, Guadalupe, Fuentes, José M., Yakhine-Diop, Sokhna M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343318/ https://www.ncbi.nlm.nih.gov/pubmed/33642386 http://dx.doi.org/10.4103/1673-5374.308080

Ejemplares similares

Toxicity of Necrostatin-1 in Parkinson’s Disease Models
por: Alegre-Cortés, Eva, et al.
Publicado: (2020)

The paradigm of protein acetylation in Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2019)

Mitochondrial Dysfunction in Repeat Expansion Diseases
por: Giménez-Bejarano, Alberto, et al.
Publicado: (2023)

Acetylome in Human Fibroblasts From Parkinson's Disease Patients
por: Yakhine-Diop, Sokhna M. S., et al.
Publicado: (2018)

Loss of KEAP1 Causes an Accumulation of Nondegradative Organelles
por: Uribe-Carretero, Elisabet, et al.
Publicado: (2022)

Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2020)

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
por: Corral Nieto, Yaiza, et al.
Publicado: (2023)

Necroptosis, necrostatins and tissue injury
por: Smith, Christopher CT, et al.
Publicado: (2011)

Biological effects of olive oil phenolic compounds on mitochondria
por: Blanco-Benítez, Mercedes, et al.
Publicado: (2022)

Neuroprotective properties of queen bee acid by autophagy induction
por: Martínez-Chacón, Guadalupe, et al.
Publicado: (2021)

mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines
por: Gómez-Sánchez, Rubén, et al.
Publicado: (2016)

Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)
por: Alegre-Cortés, Eva, et al.
Publicado: (2022)

The role of viruses in the pathogenesis of Parkinson’s disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2020)

Necrostatin-1 protection of dopaminergic neurons
por: Wu, Jing-ru, et al.
Publicado: (2015)

Hair growth promotion by Necrostatin-1s
por: Zheng, Mei, et al.
Publicado: (2020)

Effect of necrostatin-1 on sciatic nerve crush injury in rat models
por: Yu, Chen, et al.
Publicado: (2023)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Wrapping up the role of pericytes in Parkinson’s disease
por: Stevenson, Taylor John, et al.
Publicado: (2023)

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
por: Pozo Devoto, Victorio M., et al.
Publicado: (2017)

Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
por: King, Melanie D., et al.
Publicado: (2014)

Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
por: Cao, Liyuan, et al.
Publicado: (2021)

Author Correction: Hair growth promotion by Necrostatin-1s
por: Zheng, Mei, et al.
Publicado: (2021)

Falling upward with Parkinson’s disease
por: Buetow, Stephen A., et al.
Publicado: (2017)

Role of the adipocyte immune brain axis in Parkinson’s disease: friend or foe?
por: Regensburger, Martin, et al.
Publicado: (2023)

Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
por: Zhu, S, et al.
Publicado: (2011)

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
por: Takahashi, N, et al.
Publicado: (2012)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

The integrative role of G protein-coupled receptor heterocomplexes in Parkinson’s disease
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2022)

Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
por: Alarcon-Gil, Jesus, et al.
Publicado: (2022)

Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair
por: Li, Yao-Lin, et al.
Publicado: (2022)

Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis
por: Jie, Hongyu, et al.
Publicado: (2016)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Treadmill training in Parkinson’s disease: possible role of prefrontal modifications in the improved cortical-subcortical network function
por: Ding, Hao, et al.
Publicado: (2023)

The role of DJ-1 complexes and catecholamine metabolism: relevance for familial and idiopathic Parkinson’s disease
por: Piston, Dominik, et al.
Publicado: (2018)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Cell Therapies for Parkinson's Disease
por: Irion, Stefan
Publicado: (2019)

Redefining the hypotheses driving Parkinson’s diseases research
por: Farrow, Sophie L., et al.
Publicado: (2022)

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy
por: Petrosyan, Tigran
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s17sa8qrm36dtdvcic1sdm9tri